Beam Therapeutics Inc. (BEAM) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Beam Therapeutics Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BEAM vs TDOC

growth of $100 · dividends reinvested · last 7y
BEAM +30.1% (+3.8%/yr)TDOC -94.7% (-34.3%/yr)BEAM compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$130$5
BEAM TDOC

BEAM vs TDOC: by the numbers

  • •BEAM is the larger company ($2.52B vs $1.00B market cap).
  • •Both run net losses; TDOC's is the smaller (-7.13% vs -54.75% net margin).
  • •BEAM grew revenue faster over the past five years (479.04% vs 8.85% CAGR).

Metrics side by side

Valuation

MetricBEAMTDOC
P/S ratio16.150.40
P/B ratio2.360.77
EV / EBITDAN/A12.45
FCF yieldN/A22.40%

Profitability

MetricBEAMTDOC
Gross margin84.05%73.53%
Operating margin-274.57%-6.98%
Net margin-54.75%-7.13%
ROE-8.00%-13.54%
ROIC-28.96%-7.32%

Growth (annualized)

MetricBEAMTDOC
Revenue CAGR (5Y)479.04%8.85%
Total return CAGR (5Y)-22.35%-46.28%

Frequently asked

Which has grown faster, BEAM or TDOC?
Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus TDOC at 8.85%.
How have BEAM and TDOC total returns compared?
Over the past 5 years, BEAM delivered -22.35% and TDOC delivered -46.28% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.